Executive Committee

CIBC Announces Senior Executive Appointments

Retrieved on: 
Thursday, March 7, 2024

I'm looking forward to working with our Executive Committee and our entire team as we go forward."

Key Points: 
  • I'm looking forward to working with our Executive Committee and our entire team as we go forward."
  • Under Jon Hountalas' leadership as Senior Executive Vice-President (SEVP) and Group Head, Canadian Banking, our Canadian Banking business has made strong progress in attracting new clients to our bank, enhancing client experience and delivering growth.
  • Mr. Culham joined CIBC in 2008, holding key roles in Capital Markets before assuming its leadership, more recently adding accountability for Direct Financial Services, as well as overseeing CIBC's operations in the Caribbean and CIBC Mellon.
  • Region and President and CEO, CIBC Bank USA, in 2022, will continue in his current role, providing strong leadership of our U.S.

Asceneuron Expands Scientific Advisory Board with World Leading Experts in Neurodegenerative Diseases

Retrieved on: 
Wednesday, March 6, 2024

LAUSANNE, Switzerland and SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Asceneuron SA, a clinical stage biotech company dedicated to targeting the root causes of neurodegenerative diseases, today announces the appointments of neurodegenerative disease experts to its Scientific Advisory Board (SAB).

Key Points: 
  • LAUSANNE, Switzerland and SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Asceneuron SA, a clinical stage biotech company dedicated to targeting the root causes of neurodegenerative diseases, today announces the appointments of neurodegenerative disease experts to its Scientific Advisory Board (SAB).
  • Asceneuron is advancing development of its lead asset ASN51 into Phase II clinical development targeting Alzheimer's disease.
  • The Scientific Advisory Board members have vast experience in clinical trial design and biomarkers and will help support this promising program through Phase II clinical development.
  • I am honored to have these stellar neurodegenerative experts join our SAB at a fundamental time of development.

Asceneuron Expands Scientific Advisory Board with World Leading Experts in Neurodegenerative Diseases

Retrieved on: 
Wednesday, March 6, 2024

LAUSANNE, Switzerland and SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Asceneuron SA, a clinical stage biotech company dedicated to targeting the root causes of neurodegenerative diseases, today announces the appointments of neurodegenerative disease experts to its Scientific Advisory Board (SAB).

Key Points: 
  • LAUSANNE, Switzerland and SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Asceneuron SA, a clinical stage biotech company dedicated to targeting the root causes of neurodegenerative diseases, today announces the appointments of neurodegenerative disease experts to its Scientific Advisory Board (SAB).
  • Asceneuron is advancing development of its lead asset ASN51 into Phase II clinical development targeting Alzheimer's disease.
  • The Scientific Advisory Board members have vast experience in clinical trial design and biomarkers and will help support this promising program through Phase II clinical development.
  • I am honored to have these stellar neurodegenerative experts join our SAB at a fundamental time of development.

Raphaël Sanchez Appointed President of Generix Group

Retrieved on: 
Tuesday, March 5, 2024

Raphaël Sanchez is appointed President of Generix Group succeeding Aïda Collette-Sène, with a focus on accelerating growth and innovation in the cloud (SaaS).

Key Points: 
  • Raphaël Sanchez is appointed President of Generix Group succeeding Aïda Collette-Sène, with a focus on accelerating growth and innovation in the cloud (SaaS).
  • Raphaël Sanchez, who has been the Chief Revenue Officer since April 2023, succeeds Aïda Collette-Sène, who remains a shareholder.
  • This new chapter promises to be exciting and, I am convinced, will fuel the growth of our clients, partners, and of Generix Group for the years to come," states Raphaël Sanchez.
  • Raphaël Sanchez, 44 years old, joined the Generix Group Executive Committee in April 2023 as Chief Revenue Officer, tasked with rethinking the group's go-to-market strategy and accelerating its international growth.

Vistage makes key acquisition in Australia and New Zealand to set the stage for CEO peer advisory expansion

Retrieved on: 
Monday, March 4, 2024

SAN DIEGO, March 4, 2024 /PRNewswire/ -- Today Vistage announced it has acquired its licensee, TEC Australia and New Zealand, to build upon the growth of CEO peer advisory in the region.

Key Points: 
  • SAN DIEGO, March 4, 2024 /PRNewswire/ -- Today Vistage announced it has acquired its licensee, TEC Australia and New Zealand, to build upon the growth of CEO peer advisory in the region.
  • In addition, more than 45,000 Vistage members worldwide also have access to expert speakers, personalized coaching sessions, and international networking.
  • We look forward to building upon that momentum as we continue to offer peer advisory groups to more leaders in Australia and New Zealand."
  • If you are interested in becoming a Vistage Chair or member in Australia or New Zealand, visit https://tec.com.au/ or https://www.tecnz.co.nz/ .

Vaniam Group™ Hires Carol Scholz as Executive Vice President of Client Solutions

Retrieved on: 
Monday, March 4, 2024

CHICAGO, March 4, 2024 /PRNewswire/ -- Vaniam Group™ today announced the hiring of Carol Scholz as Executive Vice President of Client Solutions. In this role, Ms. Scholz will lead overall client strategy and solutions, while guiding the collaboration and growth of the Client Services department, the Scientific Communications department, and Curio Science™, Vaniam Group's industry leading platform for scientific exchange and insights gathering. She will serve as a member of the Executive Committee and report directly to Vaniam Group's President, Jennifer Buffington Herzog.

Key Points: 
  • CHICAGO, March 4, 2024 /PRNewswire/ -- Vaniam Group™ today announced the hiring of Carol Scholz as Executive Vice President of Client Solutions.
  • In this role, Ms. Scholz will lead overall client strategy and solutions, while guiding the collaboration and growth of the Client Services department, the Scientific Communications department, and Curio Science™ , Vaniam Group's industry leading platform for scientific exchange and insights gathering.
  • She will serve as a member of the Executive Committee and report directly to Vaniam Group's President, Jennifer Buffington Herzog.
  • "Carol brings a passion for delivering strategic solutions and operational excellence, always anchored in the science and centered around the needs of the patient," said Ms. Herzog.

One Call Names Matt Jenkins Chief Operating Officer

Retrieved on: 
Monday, March 4, 2024

JACKSONVILLE, Fla., March 4, 2024 /PRNewswire/ -- One Call, a care coordination leader within the workers' compensation industry, today announced that Matt Jenkins – a highly accomplished business executive – has joined the company's Executive Committee as chief operating officer (COO).    

Key Points: 
  • JACKSONVILLE, Fla., March 4, 2024 /PRNewswire/ -- One Call, a care coordination leader within the workers' compensation industry, today announced that Matt Jenkins – a highly accomplished business executive – has joined the company's Executive Committee as chief operating officer (COO).
  • Jenkins joins One Call with 25 years of experience leading business operations for complex service-oriented organizations in the financial services sector.
  • Prior to One Call, Jenkins was the chief operations officer and general manager for Oportun, a consumer-focused direct lending organization.
  • Jenkins' career also includes more than 17 years at Citi, where he capped off his tenure as managing director of global consumer operations.

Lenox Advisors Announces Strategic Expansion of Its Executive Committee

Retrieved on: 
Monday, March 4, 2024

Highlighting a progressive approach to corporate management, Kristi Vassak takes the helm as Chair of the Executive Committee.

Key Points: 
  • Highlighting a progressive approach to corporate management, Kristi Vassak takes the helm as Chair of the Executive Committee.
  • Recognized for her visionary thinking and strategic acumen, Kristi embodies the forward-looking leadership integral to steering Lenox into the future.
  • In corroborating the firm's dedication to fostering robust internal leadership, Ari Greenman joins the Executive Committee as well, offering more than 17 years of invaluable service and insight.
  • Ari's comprehensive understanding of client relations will energize Lenox's overarching strategic priorities and forge new avenues for its advisors' success.

Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands

Retrieved on: 
Monday, March 4, 2024

DUBLIN, March 4, 2024 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that Paul O'Neill has been appointed Executive Vice President, Quality & Operations, Specialty Brands, effective immediately.

Key Points: 
  • DUBLIN, March 4, 2024 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that Paul O'Neill has been appointed Executive Vice President, Quality & Operations, Specialty Brands, effective immediately.
  • Mr. O'Neill previously served as the Company's Senior Vice President, Quality & Operations, Specialty Brands.
  • He will continue to be responsible for leading Quality & Operations for Mallinckrodt's Specialty Brands business, overseeing internal and external manufacturing, supply chain distribution, device engineering, quality, technical services and product support.
  • Since joining Mallinckrodt, Mr. O'Neill has led several key initiatives in Mallinckrodt's Specialty Brands business.

PCS RETIREMENT ANNOUNCES INVESTMENT FROM LEE EQUITY PARTNERS AND NAMES SCOTT DAVID AS CEO

Retrieved on: 
Monday, March 4, 2024

PHILADELPHIA, March 4, 2024 /PRNewswire/ -- PCS Retirement ("PCS" or "the Company"), a leading retirement plan recordkeeper focused on the ERISA and Non-ERISA markets, today announced it received a majority investment from funds managed by Lee Equity Partners, LLC ("Lee Equity"), a growth oriented middle market private equity firm. As part of the transaction, LLR Partners will exit its investment in PCS. Scott David will join as CEO. Terms of the transaction were not disclosed. Founder, CEO, and industry veteran Mark Klein will be stepping away from day-to-day operations of PCS Retirement and will remain a valuable member of the Board of Directors.

Key Points: 
  • PHILADELPHIA, March 4, 2024 /PRNewswire/ -- PCS Retirement ("PCS" or "the Company"), a leading retirement plan recordkeeper focused on the ERISA and Non-ERISA markets, today announced it received a majority investment from funds managed by Lee Equity Partners, LLC ("Lee Equity"), a growth oriented middle market private equity firm.
  • Founded in 2001, PCS Retirement delivers high-quality retirement plans to business owners, school districts, municipalities, not-for-profits, and individuals.
  • "We are very appreciative of LLR's partnership and are excited to welcome Lee Equity as our financial sponsor and Scott David as CEO.
  • "PCS Retirement is a leading retirement platform with a unique go-to-market strategy and track record of innovation," said Danny Rodriguez, Partner at Lee Equity.